| Jason Cormier, MD | |
|
155 Hospital Dr, Suite 100, Lafayette, LA 70503-2852 | |
| (337) 235-7743 | |
| Not Available |
| Full Name | Jason Cormier |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 20 Years |
| Location | 155 Hospital Dr, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982812723 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 203951 (Louisiana) | Primary |
| 207T00000X | Neurological Surgery | 27335 (Alabama) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
| Lafayette Surgical Specialty Hospital | Lafayette, LA | Hospital |
| Opelousas General Health System | Opelousas, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physical Therapy Services Of West Louisiana Inc | 0446388763 | 69 |
| Neurological Associates Of Louisiana, L.l.c. | 2961301130 | 3 |
News Archive
Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute, and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer.
As Haiti continues its rebuilding efforts from the devastating earthquake that hit its largest city in January, Walgreens wrapped up its in-store giving campaign with customers donating nearly $2 million to the American Red Cross Haiti Relief and Development Fund.
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Alzheimer's therapeutic trials have gotten bad press lately, but it is not all gloom and doom. As evident at the 5th Clinical Trials in Alzheimer's Disease (CTAD) conference, held 29-31 October in the Principality of Monaco, scientists keep extracting new data from recent drug trials to gear up for a round of new ones that aim to tackle Alzheimer's earlier than ever before.
› Verified 2 days ago
| Entity Name | Neurological Associates Of Louisiana, L.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083721856 PECOS PAC ID: 2961301130 Enrollment ID: O20040107000316 |
News Archive
Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute, and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer.
As Haiti continues its rebuilding efforts from the devastating earthquake that hit its largest city in January, Walgreens wrapped up its in-store giving campaign with customers donating nearly $2 million to the American Red Cross Haiti Relief and Development Fund.
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Alzheimer's therapeutic trials have gotten bad press lately, but it is not all gloom and doom. As evident at the 5th Clinical Trials in Alzheimer's Disease (CTAD) conference, held 29-31 October in the Principality of Monaco, scientists keep extracting new data from recent drug trials to gear up for a round of new ones that aim to tackle Alzheimer's earlier than ever before.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Cormier, MD 155 Hospital Dr, Suite 100, Lafayette, LA 70503-2852 Ph: (337) 235-7743 | Jason Cormier, MD 155 Hospital Dr, Suite 100, Lafayette, LA 70503-2852 Ph: (337) 235-7743 |
News Archive
Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute, and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer.
As Haiti continues its rebuilding efforts from the devastating earthquake that hit its largest city in January, Walgreens wrapped up its in-store giving campaign with customers donating nearly $2 million to the American Red Cross Haiti Relief and Development Fund.
The U.S. Food and Drug Administration today approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegaspargase chemotherapy drugs used to treat ALL.
Alzheimer's therapeutic trials have gotten bad press lately, but it is not all gloom and doom. As evident at the 5th Clinical Trials in Alzheimer's Disease (CTAD) conference, held 29-31 October in the Principality of Monaco, scientists keep extracting new data from recent drug trials to gear up for a round of new ones that aim to tackle Alzheimer's earlier than ever before.
› Verified 2 days ago
Saul Morales Valero, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 155 Hospital Dr, Lafayette, LA 70503 Phone: 337-235-7743 | |
Patrick Alton Juneau Iii, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 206, Lafayette, LA 70508 Phone: 337-267-1319 | |
Alan J Appley, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 155 Hospital Dr, Suite 100, Lafayette, LA 70503 Phone: 337-235-7743 Fax: 337-235-7614 | |
Thomas V Bertuccini, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 601 W Saint Mary Blvd, Suite 306, Lafayette, LA 70506 Phone: 337-235-0933 Fax: 337-269-1328 | |
Dr. Ahmad Moustafa Elakil, MD, MBA Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Camellia Blvd, Lafayette, LA 70508 Phone: 337-534-4996 Fax: 337-534-4579 | |
Luiz C Dearaujo, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 116 Hospital Dr, Suite A, Lafayette, LA 70503 Phone: 337-269-6004 Fax: 337-261-9003 | |
Ms. Nancy Lynn Rogers, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 798 East Farrel Road, Lafayette, LA 70508 Phone: 337-988-0200 Fax: 337-988-0226 |